Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Injection of Autologous CD34-Positive Cells for Improved Symptomatic Relief and Ischemic Wound Healing in Subjects With Moderate or High-Risk Critical Limb Ischemia

NCT00616980 is registered in ClinicalTrials.gov with Losordo, Douglas, M.D. as lead sponsor.

NCT NCT00616980
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00616980 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Injection of Autologous CD34-Positive Cells for Improved Symptomatic Relief and Ischemic Wound Healing in Subjects With Moderate or High-Risk Critical Limb Ischemia
Lead sponsor
Losordo, Douglas, M.D.
Phase
Phase 1/2
Overall status
Completed
Start date
December 31, 2007
Completion date
August 31, 2010
Enrollment
28 (actual)
Sites
12

Conditions

As the registry lists them; a condition with its own page is linked.

critical limb ischemia, peripheral artery disease, peripheral vascular disease